Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) EV-to-EBIT : 44.62 (As of May. 31, 2025)

Oncosem Onkolojik Sistemlernayi ve Ticaret AS EV-to-EBIT Chart

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quarterly Data
	Dec19	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial											-31.35	-23.95	-50.41	-168.04	49.62

Competitive Comparison of Oncosem Onkolojik Sistemlernayi ve Ticaret AS's EV-to-EBIT

For the Medical Devices subindustry, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Oncosem Onkolojik Sistemlernayi ve Ticaret AS's EV-to-EBIT falls into.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS EV-to-EBIT Calculation

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's EV-to-EBIT for today is calculated as:

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Enterprise Value is ₺1,981.0 Mil.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺44.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS  (IST:ONCSM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Enterprise Value for the quarter that ended in Mar. 2025 was ₺2,202.8 Mil.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺44.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Oncosem Onkolojik Sistemlernayi ve Ticaret AS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Business Description